DeutschNewstral
Article
bizjournals.com on 2021-02-25 14:14
Baltimore biotech raises $4M to fuel trials for Covid vaccine, rare disease drug
Related news
Police trials stay in Baltimorenwaonline.com- St. Louis biotech startup relocates to Baltimorebizjournals.com
- Baltimore biotech developing diabetes treatments raises $20.5Mbizjournals.com
- Baltimore biotech WindMIL Therapeutics raises $32.5 millionbizjournals.com
- Baltimore biotech firm raising $111.5 millionbizjournals.com
- Former Sucampo CEO lands at Baltimore biotechbizjournals.com
Judge: Trials should be kept in BaltimoreThe Toledo Blade
Baltimore officers oppose delay of their trialsabqjournal.com- Judge: Officers’ trials to stay in Baltimoreabqjournal.com
- Eye disease startup Aurion Biotech raises $120M for clinical trialsbizjournals.com
Baltimore allots $4M for Affordable Housing Trust Fund thedailyrecord.com- Bloomberg Philanthropies pledges $4M for job training in Baltimorebizjournals.com
4M gallons of sewage, rainwater overflow to Baltimore riverSeattle Times- Baltimore Co. jury awards $4M in wrongful death casethedailyrecord.com
- $4M lawsuit alleges Baltimore correctional officers beat inmatethedailyrecord.com
Baltimore Bridge Collapse Could Fuel Reinsurance Pricingwsj.com- Baltimore biotech targeting rare diseases raises $4 millionbizjournals.com
- Baltimore biotech raises $1.6M to put toward wound healing solutionbizjournals.com